PERIOPERATIVE MYOCARDIAL ISCHEMIA: TROPONIN MONITORING, PROGNOSTIC THRESHOLDS, ECONOMIC ANALYSIS AND MORE INFORMATION ON PATHOPHYSIOLOGY
Pablo Alonso Coello
Institut de Recerca Hospital de la Santa Creu i Sant Pau
Scientific talent responds to society for the results obtained with the donations made to La Marató
Heart disease causes the death of one person in four in Catalonia and is the leading cause of hospital admission. Helping to reduce these figures by means of advances in biomedical research and raising public awareness about these diseases were the goals of La Marató in 2014. The €11,403,593 that was raised went to boost intense research of excellence, with results that will make a positive impact on the patients’ expectation and quality of life.
On 14 December 2014, TV3 and Catalunya Radio broadcast the 23rd edition of La Marató, with Mònica Terribas and Quim Masferrer presenting the TV programme, and Silvia Cóppulo on the radio. It was an intense day on which publicity, the witness of patients and entertainment went hand in hand to favour research into heart disease, while the show of support and participation were evident throughout Catalonia in the form of popular activities, volunteering and donations, among many other actions that took place during that day.
Thanks to the resources that were raised 70 leading teams in heart research ran 43 projects focused on
the prevention, diagnosis, treatment and prognosis of these diseases. Taking into account their quality, methodology, scientific, health and social relevance, innovative value and viability, the supported projects that attained the highest score among the 121 presented In answer to the call for funding from the Fundació La Marató de TV3. The evaluation process, which was co-ordinated by the Catalan Agency for Health Technology Assessment and Research (AQuAS) for the Department of Health involved 59 international scientists, specialists in heart disease.
Now, at its 21st Symposium the Foundation is publicly presenting the results of this cardiological research promoted by La Marató 2014. In view of the health emergency caused by Covid-19, the meeting has been changed to a webinar which will make it possible, under lockdown conditions, to render accounts and share with the public some promising breakthroughs that have been made possible by the selfless support, the effort and the confidence of the members of the public
Seventy research teams received grants from La Marató 2014 for 43 projects on heart disease, some single-centre projects and others co-ordinated in different centres.
PERIOPERATIVE MYOCARDIAL ISCHEMIA: TROPONIN MONITORING, PROGNOSTIC THRESHOLDS, ECONOMIC ANALYSIS AND MORE INFORMATION ON PATHOPHYSIOLOGY
Pablo Alonso Coello
Institut de Recerca Hospital de la Santa Creu i Sant Pau
IPS-DERIVED CARDIOMYOCYTES IN CARDIAC DAMAGE AND REGENERATION
Antoni Bayés Genís
Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
Mercè Martí Gaudes
Centre Medicina Regenerativa de Barcelona
MICRO-RNA AS A NEW MARKER OF CARDIOVASCULAR FIBROSIS AND ECHOCARDIOGRAPHIC PROGRESSION IN PATIENTS WITH DEGENERATIVE AORTIC STENOSIS
Begoña Benito Villabriga
Institut de Recerca Hospital Universitari Vall d'Hebron
CALIBRATION AND DISCRIMINATION OF THE SCORE (SYSTEMATIC CORONARY RISK EVALUATION) MODEL FOR LOW-RISK COUNTRIES AND THE NEW RISK EQUATION OF THE US AMERICAN COLLEGE OF CARDIOLOGY (ACC) / AMERICAN HEART ASSOCIATION (AHA)
Carlos Brotons Cuixart
EAP Sardenya
GENETIC AND MOLECULAR BASES OF RIGHT-VENTRICLE ARRHYTHMOGENIC CARDIOMYOPATHY: TRANSFER TO CLINICAL PRACTICE
Ramon Brugada Terradellas
Centre de Genètica Cardiovascular - Institut d'Investigació Biomèdica de Girona
EARLY DETECTION AND PREVENTION OF NEONATAL SUDDEN DEATH USING ECG AND MASSIVE ULTRASEQUENCING GENETIC ANALYSIS
Òscar Campuzano Larrea
Centre de Genètica Cardiovascular - Institut d'Investigació Biomèdica de Girona
MECHANISMS OF INTRACORONARY THROMBUS FORMATION DURING ACUTE MYOCARDIAL INFARCTION: A COMPREHENSIVE MORPHOLOGICAL EVALUATION OF CULPRIT LESIONS, PROTEOMIC ANALYSIS AND SYSTEMS BIOLOGY
Àngel Ramon Cequier Fillat
Hospital Universitari de Bellvitge
Sílvia Barceló Batllori
Institut d'Investigació Biomèdica de Bellvitge
DILATATION OF THE ASCENDANT AORTA AND CORONARY ANEURISMS IN PATIENTS WITH SYSTEMIC VASCULITIS (GIANT CELL ARTERITIS AND KAWASAKI DISEASE). ROLE OF THE HIF PATHWAY IN VASCULAR REMODELLING/INFLAMMATION
M. Cinta Cid Xutglà
Institut d'Investigació Biomèdica August Pi i Sunyer
Sílvia Martín Puig
Centro Nacional de Investigaciones Cardiovasculares Carlos III - Madrid
CREATION OF A NEW SYSTEM OF IMPEDANCE MAPPING FOR ELECTRICAL ABLATION OF VENTRICULAR ARRHYTHMIAS IN HUMANS: A TRANSLATIONAL APPROACH
Juna M. Cinca Cuscullola
Institut de Recerca Hospital de la Santa Creu i Sant Pau
Xavier Rosell Ferrer
Escola Tècnica Superior d'Enginyeria Industrial - Universitat Politècnica de Catalunya
WHOLE-GENOME DIAGNOSIS OF CORONARY ARTERY DISEASE
Josep Comín Colet
Institut d'Investigació Biomèdica de Bellvitge
Roderic Guigó Serra
Centre de Regulació Genòmica
IN SITU LUNG ULTRASOUND TO RULE IN HEART FAILURE PATIENTS: DIAGNOSTIC ACCURACY AND CORRELATION WITH EMERGENT CARDIAC BIOMARKERS
Maria del Mar Domingo Teixidor
Institut d'Investigació Hospital Universitari Germans Trias i Pujol
DEVELOPMENT AND APPLICATION OF ATRIAL MYOCYTE MODELS TO INVESTIGATE MECHANISMS THAT CONFER PATIENTS A HIGH RISK OF ATRIAL FIBRILLATION
Blas Echebarría Domínguez
Escola Politècnica Superior d'Edificació de Barcelona – Universitat Politècnica de Catalunya
NEW PREDICTORS OF CORONARY CARDIOPATHY: CIRCULATING ENDOTHELIAL MICROPARTICLES, FUNCTIONALITY OF THE HDL PARTICLES AND COMPOSITION IN FATTY ACIDS OF THE CELLULAR MEMBRANES
Ramon Estruch Riba
Institut d'Investigació Biomèdica August Pi i Sunyer
Montserrat Fitó Colomer
Institut Hospital Mar d'Investigacions Mèdiques
Jordi Salas Salvadó
Institut d'Investigació Sanitària Pere Virgili - Reus
ASCENDING AORTA ANEURYSM: BIOMOLECULAR AND BIOMECHANICAL FACTORS
Arturo Evangelista Masip
Institut de Recerca Hospital Universitari Vall d'Hebron
Juan Miguel Redondo Moya
Centro Nacional de Investigaciones Cardiovasculares Carlos III - Madrid
Per Eriksson
Karolinska Institutet Stockholm
MEDIUM AND LONG TERM SAFETY, EFFECTIVENESS, COST-EFFECTIVENESS, OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH ST-ELEVATION ACUTE CORONARY SYNDROME IN CLINICAL PRACTICE
Ignacio Ferreira-González
Institut de Recerca Hospital Universitari Vall d'Hebron
ASSOCIATION BETWEEN IRON STATUS AND CORONARY HEART DISEASE, DIABETES, AND STROKE: A POPULATION-BASED COHORT STUDY
Gemma Flores Mateo
Institut d'Investigació en Atenció Primària Jordi Gol - Reus
COMBINATION OF AN ADIPOSE PEDICLE WITH MYOCARDIAL MATRICES ENRICHED WITH MULTIFUNCTIONAL EXTRACELLULAR VEHICLES BY CARDIAC TISSUE ENGINEERING: PRECLINICAL AND CLINICAL STUDIES
Carolina Gálvez Montón
Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
β3 ADRENERGIC AGONIST TREATMENT IN CHRONIC PULMONARY HYPERTENSION SECONDARY TO HEART FAILURE: RANDOMIZED, PLACEBO-CONTROLLED PHASE 2 CLINICAL TRIAL
Ana García Álvarez
Hospital Clínic i Provincial de Barcelona
Valentí Fuster Carulla
Centro Nacional de Investigaciones Cardiovasculares Carlos III - Madrid
Sònia Mirabet Pérez
Institut de Recerca Hospital de la Santa Creu i Sant Pau
A RANDOMIZED COMPARISON OF THE CORONARY VASOMOTOR FUNCTION AND MYOCARDIAL FLOW IN PATIENTS TREATED WITH EVEROLIMUS-ELUTING BIORESORBABLE SCAFFOLDS AND EVEROLIMUS-ELUTING METALLIC STENTS
Josep Gómez Lara
Institut d'Investigació Biomèdica Hospital Universitari de Bellvitge
THE ADENOSINE RECEPTORS AS A NEW TARGET FOR TREATMENT OF ATRIAL FIBRILLATION: BIOMARKERS, STRATIFICATION OF THE CARDIOVASCULAR RISK AND THERAPY
Leif Hove Madsen
CSIC-Institut d'Investigacions Biomèdiques de Barcelona
Francisco Ciruela Alférez
Institut d'Investigació Biomèdica de Bellvitge
LRP1 AS A SOURCE OF THERAPEUTIC, DIAGNOSTIC AND PROGNOSTIC TOOLS IN CARDIOVASCULAR DISEASE
Concepción Vicenta Llorente Cortés
CSIC-Institut d'Investigacions Biomèdiques de Barcelona
STUDY AND MANIPULATION OF THE EMBRYONIC EPICARDIUM PROGRAM, A NEW APPROACH FOR HEART REPAIR
Ofèlia Maria Martínez Estrada
Facultat de Biologia – Universitat de Barcelona
IMMUNOREGULATORY MOLECULES AND miRNAS AS TARGETS IN CORONARY HEART DISEASE AND ACUTE CORONARY SYNDROME
José Martínez González
CSIC-Institut d'Investigacions Biomèdiques de Barcelona
Francisco Sánchez Madrid
Hospital Universitario de la Princesa - Madrid
PREVENTING PREMATURE CORONARY HEART DISEASE IN CATALONIA BY EXPANDING FAMILIAL HYPERCHOLESTEROLEMIA DIAGNOSIS
Lluís Masana Marín
Institut d'Investigació Sanitària Pere Virgili Reus – Hospital Universitari Sant Joan de Reus
Francisco Blanco Vaca
Institut de Recerca Hospital de la Santa Creu i Sant Pau
EMERGENCY ROOM IDENTIFICATION OF PATIENTS WITH LOW-RISK ACUTE HEART FAILURE AND DEVELOPMENT OF A SCALE TO IDENTIFY THEM AND IMPROVE THE EVOLUTION OF THOSE WHO ARE DISCHARGED FROM ER
Òscar Miró Andreu
Institut d'Investigació Biomèdica August Pi i Sunyer
EXPERIMENTAL AND CLINICAL STUDY OF THE RELATIONSHIP BETWEEN VANCOMYCIN MIC IN METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS (MSSA) AND THE PROGNOSIS OF LEFT-SIDED MSSA INFECTIVE ENDOCARDITIS
Josep Maria Miró Meda
Institut d'Investigació Biomèdica August Pi i Sunyer
NON INVASIVE CHARACTERISATION OF LEFT ATRIAL REMODELLING AS A PREDICTOR OF PATIENT OUTCOMES AND PROGRESSION OF ATRIAL FIBRILLATION AND TO GUIDE ABLATION PROCEDURES
Lluís Mont Girbau
Institut d'Investigació Biomèdica August Pi i Sunyer
Marta de Antonio Ferrer
Institut d'Investigació Hospital Universitari Germans Trias i Pujol
ATRIAL FIBRILLATION RESEARCH IN CATALONIA (AFRICAT)
Joan Montaner Villalonga
Institut de Recerca Hospital Universitari Vall d'Hebron
Ángel Alonso Pedrote Martínez
Hospitales Universitarios Virgen del Rocío - Sevilla
Josep Lluís Clua Espuny
CAP El Temple - Institut Català de la Salut - Tortosa
EFFECTS OF THERAPY WITH INTRAVENOUS FERRIC CARBOXYMALTOSE IN COMPARISON WITH ORAL IRON THERAPY IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AND IRON DEFICIT. PREFER
José Luís Morales Rull
Hospital Universitari Arnau de Vilanova - Lleida
ROLE OF RESIDENT MACROPHAGES AND FIBROBLASTS ON HEART REMODELING AND HEALING AFTER MYOCARDIAL INFARCTION: THE CONTRIBUTION OF THE GAS6-TAM SYSTEM
José Tomás Ortiz Pérez
Institut d'Investigació Biomèdica August Pi i Sunyer
Pablo García de Frutos
Institut Investigacions Biomèdiques de Barcelona
Andrés Hidalgo Alonso
Centro Nacional de Investigaciones Cardiovasculares Carlos III - Madrid
EARLY DIAGNOSIS OF RENAL INSUFFICIENCY IN ACUTE HEART FAILURE (EDRIAHF)
Teresa Padró Capmany
Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
.gif)
AN APPROACH FROM SYSTEMS BIOLOGY TO THE STUDY OF CONGENITAL CARDIAC MALFORMATIONS: IDENTIFICATION OF GENETIC, EPIGENETIC AND ENVIRONMENTAL FACTORS IN HUMAN AND MOUSE CARDIAC TISSUE
Luis A. Pérez Jurado
Universitat Pompeu Fabra
Alexander Damián Heine Suñer
Hospital Universitari Son Espases - Palma
ROLE OF THE NOVEL CARDIOMYOKINES FGF21 AND METRNL ON CARDIAC DAMAGE INDUCED BY ALCOHOLISM AND ARTERIAL HYPERTENSION
Anna Planavila Porta
Facultat de Biologia - Universitat de Barcelona
Joaquim Fernández Solà
Institut d'Investigació Biomèdica August Pi i Sunyer
INVESTIGATING GENETIC AND MECHANISTIC INTERACTORS IN FAMILIAL CARDIOMYOPATHY THROUGH ADVANCED DISEASE MODELING
Ángel Raya Chamorro
Centre Medicina Regenerativa de Barcelona
José Luís de la Pompa Mínguez
Centro Nacional de Investigaciones Cardiovasculares Carlos III - Madrid
Juan Ramón Gimeno Blanes
Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca - Múrcia
DETECTION OF STRUCTURAL FAULTS IN CORONARY ARTERY-IMPLANTED STENTS THROUGH NON-INVASIVE TECHNIQUES OF MICROWAVE RADIATION
Oriol Rodríguez Leor
Institut d'Investigació Hospital Universitari Germans Trias i Pujol
Javier Tejada Palacios
Facultat de Física – Universitat de Barcelona – Fundació Bosch i Gimpera
ROLE OF CONNEXIN 43 IN MYOCARDIAL SCAR FORMATION, ADVERSE LEFT VENTRICULAR REMODELING AND HEART FAILURE
Antonio Rodríguez Sinovas
Institut de Recerca Hospital Universitari Vall d'Hebron
ROLE OF ADVANCED GLYCATION END-PRODUCTS (AGES) IN ISCHEMIA-REPERFUSION INJURY OF THE AGED AND DIABETIC HEART: NEW INSIGHTS FROM MOUSE AND HUMAN STUDIES
Marisol Ruiz Meana
Institut de Recerca Hospital Universitari Vall d'Hebron
Vicente Andrés García
Centro Nacional de Investigaciones Cardiovasculares Carlos III - Madrid
NEW FUNCTIONS OF THE APOPTOTIC GENES IN THE DEVELOPMENT AND STRESS OF THE MYOCARDIUM
Daniel Sanchís Morales
Institut Recerca Biomèdica de Lleida
PATHOPHYSIOLOGICAL AND THERAPEUTIC IN VITRO ASSESSMENT OF PATIENT-SPECIFIC IPS CELL-DERIVED CARDIOMYOCYTES
Fabiana Silvia Scornik Gerzenstein
Centre de Genètica Cardiovascular – Universitat de Girona
TOWARDS AN INTEGRATED PERSONALIZED APPROACH FOR THE EARLY PREDICTION OF ATRIAL FIBRILLATION IN PATIENTS AT RISK
Marta Sitges Carreño
Institut d'Investigació Biomèdica August Pi i Sunyer
Gemma Piella Fenoy
Universitat Pompeu Fabra
EFFECTS OF CPAP TREATMENT IN DE NOVO APPEARANCE OF AF IN PATIENTS WITH NON-SERIOUS OSAS
Ermengol Vallès Gras
Institut Hospital Mar d'Investigacions Mèdiques
DIABETIC CARDIOMYOPATHY: SEARCHING FOR A THERAPEUTIC TARGET
Manuel Vázquez Carrera
Facultat de Farmàcia i Ciències de l’Alimentació - Universitat de Barcelona
Juan Francisco Nistal Herrera
Instituto de Investigación Marqués de Valdecilla - IDIVAL
INTRAVENOUS ADMINISTRATION OF A MODIFIED HMG-COA REDUCTASE INHIBITOR AS A PROMISING CARDIOPROTECTIVE STRATEGY IN ISCHEMIC HEART DISEASE: UNRAVELLING THE CARDIOPROTECTIVE BENEFITS AND MECHANISMS OF ACTION IN A PRE-CLINICAL ANIMAL MODEL WITH HIGH TRANSLATABILITY
Gemma Vilahur García
Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
